Rock Springs Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.6M	Sell	650,270 -42,268	-6%	-$1.15M	1.22%	25
2025 Q4	$18.8M	Sell	692,538 -29,000	-4%	-$764K	0.97%	33
2025 Q3	$18.7M	Sell	721,538 -91,115	-11%	-$2.11M	1.09%	31
2025 Q2	$16.5M	Hold	812,653	–	–	1.03%	32
2025 Q1	$14.7M	Sell	812,653 -409,529	-34%	-$9.15M	0.84%	44
2024 Q4	$30.9M	Buy	1,222,182 +118,404	+11%	+$3.22M	1.18%	31
2024 Q3	$37.5M	Sell	1,103,778 -295,216	-21%	-$11.2M	1.22%	33
2024 Q2	$51.8M	Buy	1,398,994 +26,809	+2%	+$1.01M	1.56%	22
2024 Q1	$57.6M	Buy	1,372,185 +402,539	+42%	+$16.5M	1.46%	22
2023 Q4	$38.5M	Buy	969,646 +469,545	+94%	+$13.8M	0.95%	37
2023 Q3	$13.8M	Buy	500,101 +78,486	+19%	+$2.46M	0.37%	65
2023 Q2	$14.3M	Buy	421,615 +111	+0%	+$3.74K	0.34%	68
2023 Q1	$15.2M	Hold	421,504	–	–	0.36%	68
2022 Q4	$18.8M	Sell	421,504 -100	-0%	-$3.57K	0.45%	60
2022 Q3	$11.9M	Buy	421,604 +86,127	+26%	+$2.64M	0.31%	72
2022 Q2	$9.04M	Buy	335,477 +238,160	+245%	+$6.92M	0.26%	81
2022 Q1	$3.31M	Buy	+97,317	New	+$3.11M	0.08%	116